Nephros (NEPH) Gross Profit (2010 - 2026)

Nephros' Gross Profit history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.

• On a quarterly basis, Gross Profit fell 5.1% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $11.5 million, a 18.31% increase from a year earlier, with the FY2025 full-year figure at $11.6 million, up 33.27% from the prior year.
• Gross Profit grew to $3.0 million in Q1 2026 per NEPH's latest filing, from $2.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $3.2 million in Q1 2025 and bottomed at $762000.0 in Q3 2022.
• The 5-year median for Gross Profit is $2.1 million (2024), against an average of $2.1 million.
• Biggest YoY gain for Gross Profit was 1365.38% in 2022; the steepest drop was 33.65% in 2022.
• Year by year, Gross Profit stood at $1.5 million in 2022, then soared by 33.93% to $2.0 million in 2023, then increased by 22.46% to $2.5 million in 2024, then gained by 11.56% to $2.8 million in 2025, then increased by 8.4% to $3.0 million in 2026.
• Per Business Quant, the three latest NEPH Gross Profit figures stand at $3.0 million (Q1 2026), $2.8 million (Q4 2025), and $2.9 million (Q3 2025).